Researchers Found These Drugs Reduced Malignant Peritoneal Mesothelioma
Researchers at MD Anderson’s Cancer Center recently announced the results of its Phase II clinical trial. The researchers found that the combination of bevacizumab and atezolizumab decreased clinical trial…